GobyMeds
GobyMeds

GobyMeds

DR34Ahrefs DR: 34/100. Below median. Measured by Ahrefs. Median 44.eDR85Effective DR: 85/100. Above median. Measured by StartupHub.ai. Median 68.Agent49Agent Readiness: 49/100. Top 25%. Measured by StartupHub.ai. Median 41.Speed35Site Speed: 35/100. Bottom 25%. Measured by Google PageSpeed. Median 62.

Personalized telehealth platform offering compounded and brand-name weight loss medications and wellness treatments with transparent pricing and no membership fees.

2023ActiveDover, United States

About

GobyMeds is a telehealth platform that provides personalized access to compounded weight loss medications like semaglutide and tirzepatide, as well as wellness treatments such as NAD+ and sermorelin. The service involves an online questionnaire, a consultation with a licensed provider through Beluga Health, P.A., and delivery of prescribed medications from licensed compounding pharmacies. GobyMeds emphasizes transparent, all-inclusive pricing without membership lock-ins.

Key facts

At-a-glance profile data

Website
gobymeds.com
Headquarters
Dover, United States
Founded
2023
Total funding
-
Business model
B2C

Tech stack

Detected on gobymeds.com, last scanned 19 Sept 2026. Run your own scan

Compliance
HIPAA
Payments
Stripe
Analytics
Google Analytics 4, Google Tag Manager, PostHog, Meta Pixel
Support
Intercom
CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Microsoft 365
Email marketing
Klaviyo
Add first review

Frequently asked

Is GobyMeds trustworthy and reputable?

StartupHub's Data Trust & Reputation score for GobyMeds is 82 out of 100, based on site security posture and privacy practices.